Neuroenhancers, addiction and research ethics
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 1470258
Author(s) Shaw, David Martin
Author(s) at UniBasel Shaw, David
Year 2012
Title Neuroenhancers, addiction and research ethics
Journal Journal of medical ethics
Volume 38
Number 10
Pages / Article-Number 605-8
Keywords Neuroethics, research ethics, neuroenhancement, addiction
Abstract

In their recent paper in this journal, Heinz and colleagues accuse proponents of cognitive enhancement of making two unjustified assumptions. The first of these is the assumption that neuroenhancing drugs will be safe; the second is that research into cognitive enhancement does not pose particular ethical problems. Heinz and colleagues argue that both these assumptions are false. Here, I argue that these assumptions are in fact correct, and that Heinz and colleagues themselves make several assumptions that undermine their argument. Neuroenhancement does raise several ethical concerns, but safety and research in this area pose no unique difficulties.

Publisher BMJ Publishing Group
ISSN/ISBN 0306-6800
URL http://jme.bmj.com/content/early/2012/08/10/medethics-2012-100616.abstract
edoc-URL http://edoc.unibas.ch/dok/A6070216
Full Text on edoc No
Digital Object Identifier DOI 10.1136/medethics-2012-100616
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/22888151
ISI-Number WOS:000309265500009
Document type (ISI) Comment, Journal Article
 
   

MCSS v5.8 PRO. 0.328 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
16/05/2022